Order Article Reprints

Lacquaniti A, Gargano R, Campo S, Casuscelli di Tocco T, Schifilliti S, Monardo P. The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis. Medicina. 2023; 59(6):1071. https://doi.org/10.3390/medicina59061071

Lacquaniti, Antonio, Romana Gargano, Susanna Campo, Teresa Casuscelli di Tocco, Silvia Schifilliti, and Paolo Monardo. 2023. "The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis" Medicina 59, no. 6: 1071. https://doi.org/10.3390/medicina59061071

Lacquaniti, A., Gargano, R., Campo, S., Casuscelli di Tocco, T., Schifilliti, S., & Monardo, P. (2023). The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis. Medicina, 59(6), 1071. https://doi.org/10.3390/medicina59061071